Continuance of trial to accept marketing approval obtained from the National Medical Products Administration for listing application of medical devices under the Medical Device Administrative Control System (MDACS)
The Medical Device Division (MDD) will continue the trial to study the feasibility for Local Responsible Persons (LRP) to demonstrate that their medical devices conform to the “Essential Principles of Safety and Performance of Medical Devices” (Technical Reference: TR-004) by presenting valid marketing approvals obtained from the National Medical Products Administration (formerly known as China Food and Drug Administration), as satisfying the conformity assessment requirements of the MDACS. The trial will last until 31 December 2020 for a limited number of listing applications of Class II/III/IV general medical devices.
If you are interested in this trial, please click here to download the application form for this trial and refer to the “Guidance Notes for Listing Class II/III /IV Medical Devices”(Guidance Notes: GN-02) to fill in the form (except items A003 and D001). The original copy of the completed application form together with the supporting documents must be submitted, by hand or by mail, to the MDD. Applicants are encouraged to provide softcopies of supporting documents in CD-ROM format as far as possible.
Medical Device Division
22 January 2020